Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Federal Medicaid Cuts
  • Generic Drugs
  • High-Deductible Plans
  • Gun Violence Trauma
  • Hospital Nutrition

WHAT'S NEW

  • Federal Medicaid Cuts
  • Generic Drugs
  • High-Deductible Plans
  • Gun Violence Trauma
  • Hospital Nutrition

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Jun 6 2023

Full Issue

Johnson & Johnson's Covid Shots Are No Longer Authorized In US

Expired doses and a lack of demand prompted the company to ask the FDA to revoke its emergency authorization. J&J “does not intend to update the strain composition of this vaccine to address emerging variants," Bloomberg reported.

Bloomberg: FDA Revokes Authorization Of J&J’s Covid Vaccine As Demand Wanes 

US regulators revoked emergency authorization for Johnson & Johnson’s Covid-19 vaccine after the company’s Janssen unit requested its withdrawal. Janssen informed the Food and Drug Administration that shots bought by the government had expired and there was no demand for the product in the US, the regulator said in a statement released last week. (Cattan, 6/5)

Reuters: Novavax Exec Says Its New COVID Shot Should Work Against Variants On The Rise

Novavax Inc's head of research and development on Monday said an updated COVID-19 vaccine the company is already producing is likely to be protective against other fast-growing coronavirus variants circulating in the U.S. Protein-based vaccines like Novavax's take longer to produce than the messenger RNA-based versions made by Moderna and Pfizer/BioNTech. (Erman, 6/5)

On the anti-vaccine movement —

Reuters: Musk Hosts Twitter Event For Anti-Vaxx Democratic Candidate RFK Jr. 

Elon Musk on Monday hosted Robert F. Kennedy Jr., the anti-vaccine activist and long-shot Democratic presidential hopeful, in his second Twitter Spaces event for a 2024 White House candidate. But unlike Republican Ron DeSantis's glitch-plagued campaign launch on Twitter in May, the live audio chat with Kennedy was broadcast without major technological problems. Their 2.5-hour conversation had an audience of over 64,000 at some points. (Bose and Singh, 6/5)

Newsweek: Jamie Foxx Becomes Figurehead Of Anti-Vax Movement

Despite the specifics of his recent illness being kept private, Jamie Foxx has become the figurehead for an anti-vax movement after a rumor went viral online. The actor was suffering from "medical complications," according to his daughter Corinne Foxx, and the family were spotted visiting him in a Chicago physical rehabilitation facility in May. With just that information and an unsubstantiated rumor started by a notable gossip columnist, some people are saying Foxx suffered a stroke brought on by a blood clot caused by a COVID vaccination. (Burton, 6/5)

In long covid research —

CIDRAP: Study Finds 27% Rate Of Long COVID In Infected Health Workers

A new case-control study of Brazilian healthcare workers (HCWs) suggests as many as 27% developed long COVID after infection, and multiple infections raised the risk. The findings were published today in Infection Control & Hospital Epidemiology. (Soucheray, 6/5)

Also —

Roll Call: Biden's Pick To Lead The CDC Faces Tough Summer On Capitol Hill 

Mandy Cohen, the former secretary of the North Carolina Department of Health and Human Services and Biden’s expected pick to head the public health agency, would take the helm at a critical time. The agency will spend this summer lobbying Congress to increase its funding and authorities via two must-pass bills: the reauthorization of a pandemic preparedness law which expires on Sept. 30, and fiscal 2024 appropriations legislation. (Cohen, 6/5)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 5
  • Monday, May 4
  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
  • Tuesday, April 28
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF